The Posterior Fossa Society - 2nd Meeting
Satellite to ISPNO Liverpool
Convention Centre – Liverpool Waterfront
Sunday June 12th, 2016
Programme
9.00-9.05
Welcome
Coriene Catsman-Berrevoets, Paediatric Neurologist, ErasmusMC/Sophia Children’s
Hospital, Rotterdam, the Netherlands
Diagnosis, Risk, Surgery, Prevention
9.05-9.45
What is Cerebellar Mutism Syndrome and can we calculate the risk in individual
children?: Results of a Delphi Consensus process.
Thora Gudrunardottir MD, Researcher, Hillerød Hospital, Copenhagen, Denmark
9.45-10.05
A new clinical scoring scale for postoperative paediatric CMS
Professor Stephanie Puget, Department of Pediatric Neurosurgery, Necker Enfants
Malades Hospital, Paris, France
10.05-10.35
Pre-operative risk stratification of CMS in children with a posterior fossa tumour
Professor David Walker, Paediatric Oncologist, Children's Brain Tumour Research Centre,
Faculty of Medicine and Health Sciences, University of Nottingham
10.35-11.00
Are disturbances of fluid and electrolyte balance risk factors for Cerebellar
Mutism Syndrome?
Coriene Catsman-Berrevoets, Associate Professor, ErasmusMC/Sophia
Children’s Hospital, Rotterdam, the Netherlands
11.00- 11.30
Coffee break
11.30- 12.30
Round table: The neurosurgical point of view; insights on avoidance Cerebellar
Mutism Syndrome in children with cerebellar tumour.
Professor Jeffrey H. Wisoff, neurosurgeon, NYU Langone Medical Center, New York, USA
Professor Robert F. Keating, neurosurgeon, Children’s National Medical Center,
George Washington University School of Medicine, Washington DC, USA
Professor Stephanie Puget, neurosurgeon, Department of Pediatric Neurosurgery, Necker
Enfants Malades Hospital, Paris, France
12.30-13.30 Lunch break
Treatment of CMS
13.30-14.00
Speech disorder after CMS; are there treatment options? Treatment of speech
and language in the acute phase
Dr. Kimberley M. Docking B.Sp.Path (Hons I), PhD Discipline of Speech Pathology |Faculty
of Health Sciences. University of Sydney, Australia
14.00-14.30
Is there any room for pharmacological treatment in pediatric postoperative PMS?
Dr Alvaro Lassaletta, Paediatric Neurooncologist, Dept of Neuro-oncology, The Hospital
for Sick Children, Toronto, Canada
14.30- 15.00
Long term outcome of PFS patients
`
Elizabeth M. Wells, MD, MHS, Medical Director, Inpatient Neurology Neuroscience
Medical Unit Director, Brain Tumor Institute, Children's National Health System
Washington DC, USA
15.00-15.30
Functional imaging and outcome in children after cerebellar tumour treatment.
Dr Nikky Pitchford PhD, School of Psychology, University of Nottingham,,UK .
15.30-15.45
Tea break
15.45-17.00
Free papers
17.00-18.00
Annual General Meeting of the Posterior Fossa Society (closed meeting)